Espace presse

The fifth HEROES auction for the benefit of Institut Imagine reaches €10 million

Innov4-ePiK: Innovative diagnostic and therapeutic approaches in potassium channel developmental and epileptic encephalopathies (K-DEEs) using 4P for medicine.

INSTITUT IMAGINE PLACES INTERNATIONAL ATTRACTIVENESS, DATA SCIENCE AND INNOVATIVE TREATMENTS AT THE HEART OF ITS ROADMAP TO 2035

CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration

Identification of a new genetic disease responsible for pulmonary alveolar proteinosis and mycobacterial infections

A new genetic disease linked to the X chromosome explains immunity problems in the face of mycobacteria

Sanofi, WhiteLab Genomics, the TaRGeT Laboratory at Nantes University, and Institut Imagine launch WIDGeT to make France a global leader in gene therapy.

« Escape Genes », the first educational Escape Game on genetics, is back at the Institut Imagine!

Launch of the Sharing Fund "Invest for Childhood": When private equity serves the common good

MEDETIA, in partnership with Institut Imagine and Inserm Transfert, launches an innovative research program with Ipsen

Isabelle André, Director of Research at Institut Imagine, joins the French Ministry of Higher Education, Research and Innovation as Scientific Director for the Health-Biology sector

Accelerating gene therapy: assessment and prospects at the end of the DIM Gene Therapy program

A new gene therapy strategy for sickle cell disease and beta thalassemia

CNX France creates engaging, positive and inspiring media for Institut Imagine

Institut Imagine, Hôpital Necker-Enfants malades AP-HP and HELEBOR collaborate in a clinical and fundamental research partnership on children's pain